Thermo Fisher Scientific unveils new Orbitrap mass spectrometers
24 Jul 2025
Aaron Robitaille from Thermo Fisher Scientific introduces two new mass spectrometers: the Orbitrap™ Astral™ Zoom and Orbitrap™ Excedion™ Pro. Hear how the Astral™ Zoom increases sample throughput and molecular detection, while the Excedion™ Pro specializes in protein therapeutic characterization. These systems build on the success of the original Astral™, expanding research capabilities into proteomics, metabolomics, lipidomics, exposomics, and plant proteomics.
This video was filmed at ASMS 2025, Baltimore, USA.
About the company

Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.




















